肿瘤干扰素信号与抑制性髓系细胞同大B细胞淋巴瘤CAR-T治疗失败相关
该研究评估了接受阿基仑赛(axi-cel)治疗的复发或难治性大B细胞淋巴瘤(LBCL)患者治疗前免疫失调与治疗失败的关系。肿瘤干扰素(IFN)信号表达、外周血单核细胞来源髓系抑制细胞(M-MDSC)水平升高及白细胞介素-6和铁蛋白水平升高均与缺乏持久缓解相关。肿瘤IFN信号与外周血M-MDSC还同axi-cel扩增减少相关。
要点
- 治疗前肿瘤IFN信号高、血M-MDSC高、IL-6和铁蛋白高均与axi-cel缺乏持久缓解相关。
- 肿瘤IFN信号与多种免疫检查点配体(含PD-L1)表达相关,且在无持久缓解者中更高。
- 肿瘤IFN信号和血M-MDSC与axi-cel扩增减少相关;高肿瘤负荷者免疫失调更明显。
核心结论
- LBCL治疗前免疫失调通过多条机制促进axi-cel耐药,包括循环M-MDSC和肿瘤IFN信号相关的axi-cel扩增不足,以及IFN信号诱导的免疫检查点配体表达。
研究设计与样本
- 研究评估接受axi-cel治疗的复发或难治性LBCL患者,分析治疗前免疫失调与治疗失败的关系。
主要发现
- 肿瘤IFN信号表达、血M-MDSC水平高、血IL-6和铁蛋白水平高分别与缺乏持久缓解相关。
- 肿瘤IFN信号与多种免疫检查点配体(包括PD-L1)表达相关,且在缺乏持久缓解的患者中更高。
- 肿瘤IFN信号和血M-MDSC与axi-cel扩增减少相关。
- 高肿瘤负荷患者血清炎症标志物和肿瘤IFN信号升高,免疫失调更明显。
临床怎么用
- 对拟接受axi-cel的LBCL患者,可关注治疗前肿瘤IFN信号、血M-MDSC、IL-6、铁蛋白及肿瘤负荷以评估免疫失调状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Axicabtagene ciloleucel (axi-cel) is a chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory large B-cell lymphoma (LBCL). This study evaluated whether immune dysregulation, present before CAR T-cell therapy, was associated with treatment failure. Tumor expression of interferon (IFN) signaling, high blood levels of monocytic myeloid-derived suppressor cells (M-MDSCs), and high blood interleukin-6 and ferritin levels were each associated with a lack of durable response. Similar to other cancers, we found that in LBCL tumors, IFN signaling is associated with the expression of multiple checkpoint ligands, including programmed cell death-ligand 1, and these were higher in patients who lacked durable responses to CAR-T therapy. Moreover, tumor IFN signaling and blood M-MDSCs associated with decreased axi-cel expansion. Finally, patients with high tumor burden had higher immune dysregulation with increased serum inflammatory markers and tumor IFN signaling. These data support that immune dysregulation in LBCL promotes axi-cel resistance via multiple mechanistic programs: insufficient axi-cel expansion associated with both circulating M-MDSC and tumor IFN signaling, which also gives rise to expression of immune checkpoint ligands.
引用
- Jain MD, Zhao H, Wang X, et al. Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma. Blood. 2021. PMID: 33512407. doi:10.1182/blood.2020007445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。